Search
for
Sort by
Research 91–120 of 1000+
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Oxidative Stress in Alopecia Areata: A Case–Control Study
- Alopecia Areata in the Indian Subcontinent
- Dietary Habits in Japanese Patients with Alopecia Areata
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- Evidence for the off-label use of tofacitinib in alopecia areata
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- 405 Recognition gap between patient and physician on disease severity and treatment satisfaction level for alopecia areata
- Dietary Habits in Japanese Patients with Alopecia Areata
- Serum Levels of Transforming Growth Factor Beta1 (TGF β1) in Patients with Alopecia Areata.
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- RỤNG TÓC VÀ SỨC KHỎE TÂM THẦN: MỐI LIÊN HỆ HAI CHIỀU VỚI LO ÂU, MẤT NGỦ VÀ CHẤT LƯỢNG CUỘC SỐNG
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Therapeutic potential of oral tofacitinib in alopecia areata: a retrospective study
- Minoxidil for patchy alopecia areata: systematic review and meta‐analysis
- Psychosocial Aspects of Hair Loss
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- Baricitinib regrows hair in adolescents with alopecia areata
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity